Found 154 matching trials
A Study of Ritonavir-Boosted Invirase (Saquinavir) in Treatment-Naïve HIV-1 Infected Patients PHASE1 This open-label study will evaluate the safety, pharmacokinetics and antivi...
Show More Location
Multiple Locations
Learn More & Join Trial
Effectiveness of Efavirenz-based Regimen in HIV-1-infected Patients With Nevirapine Hypersensitivity N/A The primary objective of this study is to compare the effectiveness of EFV-...
Show More Location
Bamrasnaradura Infectious Disease Institute
Learn More & Join Trial
Induction-Maintenance With Atazanavir in HIV Naïve Patients (The INDUMA Study) PHASE4 The purpose of this study is to compare the proportion of subjects with HIV...
Show More Location
Local Institution
Learn More & Join Trial
Third Line Antiretroviral Treatment Optimization in Sub-Saharan Africa PHASE2 Thilao is a multi-country, phase 2b, non-randomized study, in Burkina Faso,...
Show More Learn More & Join Trial
Strategy for Maintenance of HIV Suppression With Once Daily Integrate Inhibitor+Darunavir/Ritonavir in Children PHASE2 A two-arm, Phase 2/3 multicentre, open-label, randomised study evaluating s...
Show More Location
Hospital Garrahan
Learn More & Join Trial
Clinical Outcomes in HIV With Comorbidities N/A Multi-arm, non-randomized, quality of life...
Location
Prince of Wales Hospital
Learn More & Join Trial
A Study to Compare Brachial Artery Reactivity and Cardiovascular Risk of a Treatment Simplification by Darunavir/Ritonavir (DRV/r) 800/100 mg Versus a Triple Combination Therapy Containing DRV/r in HIV-1 Infected Patients PHASE2 The purpose of this study is to compare change of brachial artery flow medi...
Show More Location
Multiple Locations
Learn More & Join Trial
Drug-Drug Interactions Between Rifapentine and Dolutegravir in HIV/LTBI Co-Infected Individuals PHASE2 This study evaluated the potential drug-drug interactions between dolutegra...
Show More Location
University of California HIV/AIDS CRS
Learn More & Join Trial
CCR5 Inhibitor Treatment Intensification on CD4+ T-cell Recovery PHASE4 CCTG 590 is a open-label study to evaluate the impact of therapy intensific...
Show More Location
University Southern California
Learn More & Join Trial
A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments PHASE4 The goal of this clinical study is to provide continued access to the study...
Show More Learn More & Join Trial